These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2506409)

  • 21. Prevalence of protease and elastase production by clinical isolates of Pseudomonas aeruginosa in relation to aeruginocine typing patterns.
    Kapur R; Shriniwas
    Eur J Epidemiol; 1986 Sep; 2(3):182-5. PubMed ID: 3098577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peptidase activity and toxicity of strains of Pseudomonas aeruginosa].
    Pinna GG; Spano A; Carru C; Pes GM; Delogu G; Miscali AR; Zanetti S; Sisini A
    Boll Soc Ital Biol Sper; 1991 Mar; 67(3):287-94. PubMed ID: 1930904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotyping and virulence factors of Pseudomonas aeruginosa clinical isolates.
    Hostacká A; Majtán V
    Acta Microbiol Immunol Hung; 1997; 44(2):141-6. PubMed ID: 9330662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
    Estrellas PS; Alionte LG; Hobden JA
    Curr Eye Res; 2000 Mar; 20(3):157-65. PubMed ID: 10694889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular toxins of Pseudomonas aeruginosa. IV. Radioimmunoassay for detection of elastase.
    Obernesser HJ; Döring G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):248-56. PubMed ID: 6812322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of subinhibitory concentrations of norfloxacin, erythromycin and roxithromycin on Pseudomonas aeruginosa virulence factors].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):115-7. PubMed ID: 7489133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.
    Kharazmi A; Høiby N; Döring G; Valerius NH
    Infect Immun; 1984 Jun; 44(3):587-91. PubMed ID: 6327528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent progress of Pseudomonas aeruginosa infections; pathological mechanisms of new toxic metabolites].
    Homma JY
    Nihon Rinsho; 1991 Oct; 49(10):2201-6. PubMed ID: 1749074
    [No Abstract]   [Full Text] [Related]  

  • 29. Interaction of Pseudomonas aeruginosa alkaline protease and elastase with human polymorphonuclear leukocytes in vitro.
    Kharazmi A; Döring G; Høiby N; Valerius NH
    Infect Immun; 1984 Jan; 43(1):161-5. PubMed ID: 6317565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic specificities of Pseudomonas aeruginosa alkaline protease and elastase defined by human T cell clones.
    Parmely MJ; Horvat RT
    J Immunol; 1986 Aug; 137(3):988-94. PubMed ID: 2424995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of exotoxin, protease and elastase of Pseudomonas aeruginosa strains isolated from patients' and environmental specimens.
    Sanai Y; Takeshi K; Homma JY; Kamata H
    Jpn J Exp Med; 1978 Dec; 48(6):553-6. PubMed ID: 108441
    [No Abstract]   [Full Text] [Related]  

  • 32. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease & elastase production & their association with aeruginocine & pigment production by clinical isolates of Pseudomonas aeruginosa.
    Kapur R; Shriniwas
    Indian J Med Res; 1987 Jan; 85():10-3. PubMed ID: 3108152
    [No Abstract]   [Full Text] [Related]  

  • 34. Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.
    Heck LW; Morihara K; Abrahamson DR
    Infect Immun; 1986 Oct; 54(1):149-53. PubMed ID: 3093382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspects on the molecular genetics of Pseudomonas aeruginosa; elastase, alkaline protease and other pathogenic factors].
    Fukushima J; Inami S; Okuda K
    Nihon Rinsho; 1991 Oct; 49(10):2220-6. PubMed ID: 1684213
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of growth media on potential virulence factors of Pseudomonas aeruginosa.
    Hostacká A
    Cent Eur J Public Health; 2003 Sep; 11(3):129-31. PubMed ID: 14514163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mutational analysis of genes involved in elastin hydrolysis in Pseudomonas aeruginosa].
    Jin Y; Li T; Xia H; Gu C; Zhang X; Bai Y; Xu H; Qiao M
    Wei Sheng Wu Xue Bao; 2008 Dec; 48(12):1623-8. PubMed ID: 19271537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of multiple Pseudomonas aeruginosa strains with different characteristics in clinical specimens; combined results from serotyping, drug susceptibility and enzyme production].
    Nakasone I; Kusano N; Hokama S
    Rinsho Byori; 1995 Nov; 43(11):1135-9. PubMed ID: 8551677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhamnolipid production: effect of oxidative stress on virulence factors and proteome of Pseudomonas aeruginosa PA1.
    Pacheco GJ; Reis RS; Fernandes AC; da Rocha SL; Pereira MD; Perales J; Freire DM
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1519-29. PubMed ID: 22782250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.